ImmunityBio Inc (NASDAQ: IBRX) is -31.47% lower on its value in year-to-date trading and has touched a low of $1.25 and a high of $10.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $3.52 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $3.44, the stock is -6.75% and -22.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.89 million and changing -2.27% at the moment leaves the stock -33.89% off its SMA200. IBRX registered 110.40% gain for a year compared to 6-month loss of -43.33%.
The stock witnessed a -17.31% gain in the last 1 month and extending the period to 3 months gives it a -53.13%, and is -1.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.86% over the week and 6.57% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $2.40B and $1.31M in sales. Profit margin for the company is -45691.67%. Distance from 52-week low is 175.20% and -67.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.07%).
The EPS is expected to grow by 25.22% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
259.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 39.82% of the company’s shares. The shares outstanding are 670.87M, and float is at 159.51M with Short Float at 32.16%. Institutions hold 9.14% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0558% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6978 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1688% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5822 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
